Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Linde Group (The)    LIN   DE0006483001

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Ad hoc-announcement: Linde AG: Status of the merger clearance proceedings for the proposed business combination with Praxair

share with twitter share with LinkedIn share with facebook
share via e-mail
03/19/2018 | 03:16pm CET

Munich - Linde Aktiengesellschaft ('Linde') was informed today about the decision of the European Commission to suspend the review period for the merger clearance process regarding the business combination of Linde and Praxair, Inc. ('Praxair') with retroactive effect as of 24 February 2018 until information requested by the European Commission will be provided.

Such decisions are not uncommon in complex proceedings of this kind. Linde expects that the suspension will be lifted in the course of next week and that the review period will then continue to run. The merger partners continue to work on completing the business combination as planned in the second half of 2018.

Forward-looking Statements

This communication includes 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are based on our beliefs and assumptions on the basis of factors currently known to us. These forward-looking statements are identified by terms and phrases such as: anticipate, believe, intend, estimate, expect, continue, should, could, may, plan, project, predict, will, potential, forecast, and similar expressions. These forward-looking statements include, but are not limited to, statements regarding benefits of the proposed business combination, integration plans and expected synergies, and anticipated future growth, financial and operating performance and results. Forward-looking statements involve risks and uncertainties that may cause actual results to be materially different from the results predicted or expected. No assurance can be given that these forward-looking statements will prove accurate and correct, or that projected or anticipated future results will be achieved. Factors that could cause actual results to differ materially from those indicated in any forward-looking statement include, but are not limited to: the expected timing and likelihood of the completion of the contemplated business combination, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the contemplated business combination that could reduce anticipated benefits or cause the parties to abandon the transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination agreement; the ability to successfully complete the proposed business combination and the exchange offer; regulatory or other limitations imposed as a result of the proposed business combination; the success of the business following the proposed business combination; the ability to successfully integrate the Praxair and Linde businesses; risks related to disruption of management time from ongoing business operations due to the proposed business combination; the risk that the announcement or consummation of the proposed business combination could have adverse effects on the market price of Linde's or Praxair's common stock or the ability of Linde and Praxair to retain customers, retain or hire key personnel, maintain relationships with their respective suppliers and customers, and on their operating results and businesses generally; the risk that Linde plc may be unable to achieve expected synergies or that it may take longer or be more costly than expected to achieve those synergies; state, provincial, federal and foreign legislative and regulatory initiatives that affect cost and investment recovery, have an effect on rate structure, and affect the speed at and degree to which competition enters the industrial gas, engineering and healthcare industries; outcomes of litigation and regulatory investigations, proceedings or inquiries; the timing and extent of changes in commodity prices, interest rates and foreign currency exchange rates; general economic conditions, including the risk of a prolonged economic slowdown or decline, or the risk of delay in a recovery, which can affect the long-term demand for industrial gas, engineering and healthcare and related services; potential effects arising from terrorist attacks and any consequential or other hostilities; changes in environmental, safety and other laws and regulations; the development of alternative energy resources; results and costs of financing efforts, including the ability to obtain financing on favorable terms, which can be affected by various factors, including credit ratings and general market and economic conditions; increases in the cost of goods and services required to complete capital projects; the effects of accounting pronouncements issued periodically by accounting standard-setting bodies; conditions of the debt and capital markets; market acceptance of and continued demand for Linde's and Praxair's products and services; changes in tax laws, regulations or interpretations that could increase Praxair's, Linde's or Linde plc's consolidated tax liabilities; and such other factors as are set forth in Linde's annual and interim financial reports made publicly available and Praxair's and Linde plc's public filings made with the SEC from time to time, including but not limited to those described under the headings 'Risk Factors' and 'Forward-Looking Statements' in Praxair's Form 10-K for the fiscal year ended December 31, 2017, which are available via the SEC's Web site at www.sec.gov. The foregoing list of risk factors is not exhaustive. These risks, as well as other risks associated with the contemplated business combination, are more fully discussed in the proxy statement/prospectus and the offering prospectus included in the Registration Statement on Form S-4 filed by Linde plc with the SEC and in the offering document and/or any prospectuses or supplements filed with BaFin in connection with the contemplated business combination. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than Linde, Praxair or Linde plc has described. All such factors are difficult to predict and beyond our control. All forward-looking statements included in this document are based upon information available to Linde, Praxair and Linde plc on the date hereof, and each of Linde, Praxair and Linde plc disclaims and does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

(C) 2018 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
PRAXAIR -3.07% 149.58 Delayed Quote.-0.23%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on LINDE GROUP (THE)
03/19AD HOC-ANNOUNCEMENT : Linde AG: Status of the merger clearance proceedings for t..
03/16LINDE AG : Notification and public disclosure of transactions by persons
03/16LINDE AG : Notification and public disclosure of transactions by persons
03/16LINDE AG : Notification and public disclosure of transactions by persons
03/16LINDE AG : Notification and public disclosure of transactions by persons
03/16LINDE AG : Notification and public disclosure of transactions by persons
03/16LINDE AG : Notification and public disclosure of transactions by persons
03/16LINDE AG : Notification and public disclosure of transactions by persons
03/16GAZPROM : Export and Linde sign Helium Sales and Purchase Agreement
03/15LINDE : EU suspends review of Linde-Praxair merger, but should resume - Linde
More news
News from SeekingAlpha
03/15Linde (LNEGY) Presents At Goldman Sachs 7th Annual European Chemicals Confere.. 
03/08Linde AG 2017 Q4 - Results - Earnings Call Slides 
03/08REUTERS : Praxair, Linde seeking bids for their planned divestitures this month 
03/08Linde's (LNAGF) CEO Dr. Aldo Belloni on Q4 2017 Results - Earnings Call Trans.. 
03/08Linde AG reports FY results 
Financials (€)
Sales 2018 17 286 M
EBIT 2018 2 416 M
Net income 2018 1 504 M
Debt 2018 5 371 M
Yield 2018 2,28%
P/E ratio 2018 21,87
P/E ratio 2019 20,08
EV / Sales 2018 2,17x
EV / Sales 2019 2,06x
Capitalization 32 225 M
Duration : Period :
Linde Group (The) Technical Analysis Chart | LIN | DE0006483001 | 4-Traders
Technical analysis trends LINDE GROUP (THE)
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 204 €
Spread / Average Target 17%
EPS Revisions
Aldo Belloni Chief Executive Officer
Wolfgang W. Reitzle Chairman-Supervisory Board
Sven Schneider Chief Financial Officer & Member-Executive Board
Andreas Opfermann Head-Technology & Innovation
Sandeep Sen Head-Group Information Services
Sector and Competitors
1st jan.Capitalization (M$)
LINDE GROUP (THE)-4.36%39 789
AIR WATER INC-14.95%3 837